<SEC-DOCUMENT>0000899243-19-030243.txt : 20191231
<SEC-HEADER>0000899243-19-030243.hdr.sgml : 20191231
<ACCEPTANCE-DATETIME>20191231095514
ACCESSION NUMBER:		0000899243-19-030243
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20191231
DATE AS OF CHANGE:		20191231

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			RUDYK JAMES DANIEL
		CENTRAL INDEX KEY:			0001796640

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		191318271

	MAIL ADDRESS:	
		STREET 1:		320-720 KING STREET WEST
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2T3

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		720 KING STREET W
		STREET 2:		SUITE 320
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2T3
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		720 KING STREET W
		STREET 2:		SUITE 320
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2T3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2019-12-31</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001656472</issuerCik>
        <issuerName>Cronos Group Inc.</issuerName>
        <issuerTradingSymbol>CRON</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001796640</rptOwnerCik>
            <rptOwnerName>RUDYK JAMES DANIEL</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>720 KING STREET WEST, SUITE 320</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>TORONTO</rptOwnerCity>
            <rptOwnerState>A6</rptOwnerState>
            <rptOwnerZipCode>M5V 2T3</rptOwnerZipCode>
            <rptOwnerStateDescription>ONTARIO, CANADA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>COMMON SHARES</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>36237</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>COMMON SHARE OPTION (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>9.00</value>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2023-01-31</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>COMMON SHARES</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>109375</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>COMMON SHARE OPTION (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>7.57</value>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2023-05-17</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>COMMON SHARES</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>118750</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>DEFERRED SHARE UNITS</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F5"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>COMMON SHARES</value>
                    <footnoteId id="F4"/>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>8484.16</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The options were granted January 31, 2018 and vest in monthly installments over a four-year period.</footnote>
        <footnote id="F2">The exercise price is expressed in Canadian dollars.</footnote>
        <footnote id="F3">The options were granted May 17, 2018 and vest in monthly installments over a four-year period.</footnote>
        <footnote id="F4">Vested Deferred Share Units are mandatorily redeemable by Cronos Group Inc. (the &quot;Company&quot;) on the first trading day after Mr. Rudyk ceases to be a director of the Company.</footnote>
        <footnote id="F5">Upon redemption, Deferred Share Units entitle Mr. Rudyk to receive a lump sum cash payment in an amount equal to the fair market value of Company common shares on the date of redemption.</footnote>
    </footnotes>

    <remarks>Exhibit List: Exhibit 24 - Power of Attorney

This Form 3 is being filed in advance of January 1, 2020, on which date the reporting person will become subject to Section 16 of the Securities Exchange Act of 1934, as amended.</remarks>

    <ownerSignature>
        <signatureName>/s/ Xiu Ming Shum as Attorney-in-Fact for James D. Rudyk</signatureName>
        <signatureDate>2019-12-31</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>attachment1.htm
<DESCRIPTION>EX-24 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>
James Daniel Rudyk - Exhibit 24


                         Authorization and Designation
                                to Sign and File
                           Section 16 Reporting Forms


        The undersigned, a director of Cronos Group Inc., a corporation formed
under the Business Corporations Act (Ontario) (the "Company"), does hereby
authorize and designate Jerry Barbato or Xiu Ming Shum, each with right to
substitute and resubstitute, but for only so long as each of them is an officer
of the Company, to sign and file on his or her behalf the application for the
required Securities and Exchange Commission ("SEC") electronic CIK/CCC codes and
any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the
Company with the SEC pursuant to the requirements of Section 16 of the
Securities Exchange Act of 1934 ("Section 16") and Rule 144 under the Securities
Act of 1933, as amended.  This authorization, unless earlier revoked in writing,
shall be valid until the undersigned's reporting obligations under Section 16
and Rule 144 with respect to equity securities of the Company shall cease.  All
prior such authorizations are hereby revoked.

        IN WITNESS WHEREOF, the undersigned has executed this Authorization and
Designation this 9 day of Dec, 2019.




                                        /s/ James Daniel Rudyk
                                        ---------------------------------------
                                        James Daniel Rudyk



</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
